(Q42873289)

English

Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients.

scientific article published on 29 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

T N Kakuda

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

E Snoeck

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

P Vis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Schöller-Gyüre

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M P Peeters

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Corbett

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

S Nijs

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J Vingerhoets

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

L Leopold

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G De Smedt

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B J Woodfall

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R M W Hoetelmans

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

0 references

publication date

29 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

88

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

695-703

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug interactions with new and investigational antiretrovirals

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of different meal compositions and fasted state on the oral bioavailability of etravirine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Efavirenz concentrations in HIV-infected patients with and without viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: an open-label, multiple-dose, controlled Phase I study in adults

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

"White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic Parameters of Nevirapine and Efavirenz in Relation to Antiretroviral Efficacy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.181

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2010.181

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20881958%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42873289&oldid=2143970546"